“CONCLUSION: A single dose of misoprostol administered in the outpatient setting significantly decreases oxytocin use, largely due to labor within the ripening period.”
“Despite the numerous trials examining misoprostol for induction, the efficacy of a single outpatient dose of misoprostol followed by oxytocin induction is unknown.”
“RESULTS: A single dose of misoprostol significantly decreased the cumulative dose of oxytocin , the cumulative time of oxytocin administration, and the dose intensity of oxytocin (dose divided by time).”